Ê×Ò³×÷ÎÄËزĺôʺþäÀúÊ·µä¹Êд×÷¼¼ÇÉ¿¼³¡Ëزĵ¥Ôª×÷ÎÄÓ¢Óï×÷ÎÄСÉý³õ×÷ÎÄÃûÈ˹ÊÊÂʱÊÂÂÛ¾Ý ÃûÑÔ¾¯¾ä·¶ÎÄ´óÈ«¾«ÃÀÉ¢ÎÄ
Сѧ×÷ÎÄ
³õÖÐ×÷ÎÄ
¸ßÖÐ×÷ÎÄ
×÷ÎÄÌå²Ã

ÄÚ¿Æҽѧ±ÏÒµÂÛÎÄ

ʱ¼ä£º2023-06-25 09:40:17 À´Ô´£º°®×÷ÎÄÍø  °®×÷ÎÄÍøÊÖ»úÕ¾

ºôÎüÄڿƲ¡·¿ÔºÄڷβ¿Õæ¾ú¸ÐȾµÄÁÙ´²·ÖÎö
¡¾ÕªÒª¡¿Ä¿µÄ ̽ÌÖÉϺ£ÖÐÒ½Ò©´óѧ¸½ÊôÆÕÍÓÒ½ÔººôÎüÄڿƲ¡·¿»¼Õ߷β¿Õæ¾ú¸ÐȾ·¢²¡µÄÒ×»¼ÒòËØ¡¢ÁÙ´²ÌØÕ÷ºÍÖÎÁÆ¡£·½·¨ ²ÉÓûعËÐÔµ÷²é·½·¨¶Ô2005Äê6Ô¡«2006Äê12ÔÂÊÕסÄڿƵľ­Î¢ÉúÎï¼ì²é֤ʵ54Àý¼Ì·¢·Î²¿Õæ¾ú¸ÐȾµÄ»¼Õß½øÐзÖÎö¡£½á¹û ÔÚºôÎüÄڿƲ¡·¿ÖУ¬ÔºÄڷβ¿Õæ¾ú¸ÐȾ·¢ÉúÂÊΪ3ª±8%£¬ÂýÐÔ×èÈûÐԷμ²²¡£¨51ª±8%£©ÊǼ̷¢ÔºÄڷβ¿Õæ¾ú¸ÐȾ×î³£¼ûµÄ»ù´¡¼²²¡£¬³¤ÆÚʹÓùãÆ׿¹ÉúËØ£¨96ª±3%£©¡¢µÍµ°°×Ѫ֢£¨59ª±3%£©¡¢³¤ÆÚʹÓÃÌÇƤÖʼ¤ËØ£¨33ª±3%£©¼°ºÏ²¢ÌÇÄò²¡ÊÇÖ÷ÒªÒ×»¼ÒòËØ¡£·Î²¿Õæ¾ú¸ÐȾµÄÁÙ´²±íÏÖÎÞÌØÒìÐÔ£¬È·ÕïÐè½áºÏ̵ÅàÑø£¬×éÖ¯²¡ÀíѧºÍÁÙ´²±íÏÖÀ´È·¶¨£¬²¡Ô­¾úÒÔ°×É«¼ÙË¿½Íĸ¾ú£¨61ª±1%£©ÎªÖ÷£¬·ú¿µßòÖÎÁÆÓÐЧÂÊ92ª±2%¡£½áÂÛ ÔºÄڷβ¿Õæ¾úÊǺôÎüϵͳ¼²²¡¼Ì·¢¸ÐȾµÄÖØÒª²¡Ô­Ì壬¶ø°×É«¼ÙË¿½Íĸ¾úÊÇÔºÄڷβ¿Õæ¾ú¸ÐȾµÄÖ÷ÒªÖ²¡¾ú£¬ÓÐЧµÄ¿¹Õæ¾úÖÎÁÆÍ⣬»ý¼«µÄ×ÛºÏÖÎÁÆÓÐÖúÓÚÌá¸ßÕæ¾ú¸ÐȾµÄÖÎÓúÂÊ¡£

¡¡¡¡¡¾¹Ø¼ü´Ê¡¿  ·Î£»
ÔºÄÚ¸ÐȾ£»
Õæ¾ú

¡¡¡¡Analysis on nosocomial pulmonary fungal infection in respiratory department ward

¡¡¡¡CAI Zhu-ying£¬TANG Ji-hong£¬WANG Lei£¬et al.Department of Respiratory Diseases£¬Putuo Hospital£¬Shanghai University of TCM£¬Shanghai 200062£¬China

¡¡¡¡£ÛAbstract£Ý  Objective  To study the susceptible factors£¬clinical features and treatments of nosocomial pulmonary fungal infection in the ward of respiratory department.Methods  The chart files of 54 patients with nosocomial pulmonary fungal infection admitted from June 2005 to December 2006 in the ward of Respiratory Department were reviewed.Results  The incidence rate of nosocomial pulmonary fungal infection was 3ª±8%.COPD(51ª±8%)was the main predisposing disease£¬and candidiasis(61ª±1%) was the most common pathogen. The main susceptible factors associated with nosocomial pulmonary fungal infection are long-term use of broad-spectrum antibiotics(96ª±3%)£¬hypoalbuminemia(59ª±3%)£¬long-term use of adrenocortical steroid(33ª±3%)£¬and diabetes mellitus.There is no specific clinical feature.Fluconazole(92ª±2%)is more efficient in the treatment.Conclusion  Nosocomial pulmonary fungis are important pathogenin the secondary infection in respiratory disease.The most common pathogen is candida albicans.Combined therapy as well as treating fungus infection are important measures to increase the cure rate of nosocomial pulmonary fungal infection
£ÛKey words£Ý  lung£»
nosocomial infection£»
fungal

¡¡¡¡Õæ¾úÊôÓÚÌõ¼þÖ²¡¾ú£¬Ö»ÓÐÔÚ»úÌåÃâÒß¹¦ÄܵÍÏ»ò¾úȺʧµ÷ʱ²ÅÒýÆð¸ÐȾ¡£½üÄêÀ´£¬Ëæ׏ãÆ׿¹ÉúËØ¡¢ÌÇƤÖʼ¤ËØ¡¢ÃâÒßÒÖÖƼÁµÄ³¤ÆÚÓ¦Óã¬ÒÑÓÐһЩÂýÐÔ²¡Éú´æʱ¼äÑÓ³¤£¬¸÷ÖÖµ¼¹Ü½éÈëÐÔÖÎÁƺÍÆ÷¹ÙÒÆÖ²ÖÎÁƵÄÉîÈ뿪չ£¬ÏµÍ³ÐÔÕæ¾ú¸ÐȾµÄ·¢²¡Âʲ»¶ÏÔö¼Ó£¬ÆäÖкôÎüϵͳÕæ¾ú¸ÐȾռËùÓÐÄÚÔàÕæ¾ú¸ÐȾµÄÊ×λ¡£ÔºÄÚÕæ¾ú¸ÐȾÕß¾ø´ó¶àÊý»¼Óлù´¡¼²²¡£¬ÆäÖÐÒÔºôÎüϵͳ¼²²¡Îª¶à¼û£Û1£Ý¡£±¾ÎIJÉÓûعËÐÔµ÷²éµÄ·½·¨£¬¶Ô2005Äê6Ô¡«2006Äê12ÔºôÎüÄÚ¿ÆסԺµÄ54Àý·Î²¿Õæ¾ú¸ÐȾ²¡Àý½øÐÐÁËÁÙ´²×ÊÁÏ¡¢²¡Ô­Ñ§·Ö²¼µÄµ÷²é¡£

¡¡¡¡1  ×ÊÁÏÓë·½·¨

¡¡¡¡1ª±1  Ò»°ã×ÊÁÏ  2005Äê6Ô¡«2006Äê12ÔÂÔÚÉϺ£ÖÐÒ½Ò©´óѧ¸½ÊôÆÕÍÓÒ½ÔººôÎüÄÚ¿ÆסԺÆڼ䷢Éú·Î²¿Õæ¾ú¸ÐȾµÄÓкôÎüϵͳ»ù´¡¼²²¡µÄ²¡Àý54Àý¡£ÆäÖÐÄÐ33Àý£¬Å®21Àý£¬ÄêÁä47¡«99Ë꣬ƽ¾ùÄêÁä75Ëê¡£

¡¡¡¡1ª±2  Õï¶Ï±ê×¼  ÔºÄڷβ¿Õæ¾ú¸ÐȾÒÔ2006ÄêÖлªÄÚ¿ÆÔÓÖ¾±à¼­Î¯Ô±»á·¢²¼µÄ¡¶ÇÖÏ®ÐԷβ¿Õæ¾ú¸ÐȾµÄÕï¶Ï±ê×¼ÓëÖÎÁÆÔ­Ôò£¨²Ý°¸£©¡·×÷ΪÒÀ¾Ý£Û2£Ý¡£

¡¡¡¡1ª±3  ÁÆЧÆÀ¶¨±ê×¼  ȬÓú£ºÁÙ´²Ö¢×´Ïûʧ£¬·Î²¿ÒõÓ°ÎüÊÕ¡£ºÃת£ºÁÙ´²Ö¢×´¼õÇᣬ·Î²¿ÒõӰδÍêÈ«ÎüÊÕ¡£Îޱ仯£ºÁÙ´²Ö¢×´ºÍ·Î²¿ÒõÓ°¾ùÎޱ仯¡£¶ñ»¯£ºÁÙ´²Ö¢×´¼ÓÖØ£¬·Î²¿ÒõÓ°Ôö¶à¡£

¡¡¡¡1ª±4  Ñо¿·½·¨  ±¾×é×ÊÁϲÉÓûعËÐÔ·ÖÎö·½·¨£¬¶Ô²¡Ê·×ÊÁÏ¡¢Ò×»¼ÒòËØ¡¢Õï¶Ï¡¢ÖÎÁƼ°Ô¤ºó½øÐÐ×ܽáºÍ·ÖÎö¡£

¡¡¡¡1ª±5  ͳ¼Æѧ·½·¨  ÓйØÊý¾ÝÒÔ¾ùÊý¡À±ê×¼²î(x¡Às)±íʾ£¬²¢¼ÆËã°Ù·Ö±È¼°Í³¼ÆÁбíµÈ¡£

¡¡¡¡2  ½á¹û

¡¡¡¡2005Äê6Ô¡«2006Äê12ÔÂÎÒÔººôÎüÄÚ¿ÆסԺ»¼Õß1427Àý£¬ÆäÖÐ54Àý·¢ÉúÁËÔºÄڷβ¿Õæ¾ú¸ÐȾ£¬ÔºÄڷβ¿Õæ¾ú¸ÐȾÂÊΪ3ª±8%¡£ÆäÖÐÈ·ÕﲡÀý3Àý£¬ÁÙ´²Õï¶Ï²¡Àý51Àý¡£ËÀÍö3Àý£¬ËÀÍöÂÊΪ5ª±6%¡£

¡¡¡¡2ª±1  »ù´¡¼²²¡  ÔºÄڷβ¿Õæ¾ú¸ÐȾ¿É·¢ÉúÔÚ¶àÖÖºôÎüϵͳ¼²²¡µÄ»ù´¡ÉÏ£¬±¾×é×ÊÁÏÖÐÒÔÂýÐÔ×èÈûÐԷμ²²¡£¨28Àý£¬Õ¼51ª±8%£©×îΪ¶à¼û£¬·ÎÑ×¼°Ïø´­·Ö±ðÕ¼22ª±2%ºÍ11ª±1%£¬¼û±í1¡£

¡¡¡¡2ª±2  ¸ÐȾµÄÒ×»¼ÒòËØ  ³¤Ê±¼äÓ¦ÓùãÆ׿¹ÉúËØ£¨Ö¸¾²Âö¼°¿Ú·þÓ¦ÓùãÆ׿¹ÉúËس¬¹ý2ÖÜ£©52Àý£¨96ª±3%£©£¬×î¶Ì3Ì죬×ʱ¼ä15Ì죬ºÏ²¢µÍµ°°×Ѫ֢£¨Ö¸ÑªÇå°×µ°°×<35 g/L£©32Àý£¨59ª±3%£©£¬³¤ÆÚÓ¦ÓÃÌÇƤÖʼ¤ËØ£ÛÖ¸¾²Âö»ò¿Ú·þÏ൱ÓÚÇ¿µÄËÉ0ª±5 mg/(kg¡¤d)ÒÔÉϼÁÁ¿µÄÌÇƤÖʼ¤Ëس¬¹ý2ÖÜ£ÝÕß18Àý£¨33ª±3%£©£¬ºÏ²¢ÌÇÄò²¡14Àý£¨25ª±9%£©¡£´ËÍ⣬54ÀýÖкϲ¢2ÖÖ»ò2ÖÖÒÔÉÏ¿ÉÄÜÒ×»¼ÒòËصĻ¼Õß46Àý£¨85ª±2%£©£¬¼û±í2¡£
2ª±3  ·Î²¿Õæ¾ú¸ÐȾµÄÕæ¾úÀàÐÍ  ·Î²¿Õæ¾ú¸ÐȾµÄÖ÷Òª²¡Ô­¾úÊǽÍĸ¾úÊô£¬±¾×é×ÊÁÏÖнÍĸ¾úÊô51Àý£¨94ª±4%£©£¬ÆäÖа×É«¼ÙË¿½Íĸ¾ú33Àý£¨61ª±1%£©¡£Æä´ÎΪÇúù¾úÊô£¬¼û±í3¡£±í1  ·Î²¿Õæ¾ú¸ÐȾÏà¹Ø»ù´¡¼²²¡±í2  54Àý·Î²¿Õæ¾ú¸ÐȾµÄÒ×»¼ÒòËرí3  54Àý·Î²¿Õæ¾ú¸ÐȾµÄÕæ¾úÀàÐÍ

¡¡¡¡2ª±4  ÁÙ´²ÌØÕ÷  ÁÙ´²±íÏÖÉϾù¿ÉÓв»Í¬³Ì¶ÈµÄ¿ÈËÔ¡¢¿È̵¡¢·¢ÈȵÈÖ¢×´£¬ÓÐÎÞɫ͸Ã÷µÄ¡°À­Ë¿¡±Ñù̵42Àý£¨77ª±8%£©£¬¿ÚÇ»ÄÚ¼Õð¤Ä¤¡¢Éà±íÃæ¿É¼û°×É«°ßµã30Àý£¨55ª±6%£©£¬·Î²¿Õæ¾ú¸ÐȾÔÚXÏßÐØƬ»òÐز¿CTÉϵıíÏÖÒ²ÎÞÌØÒìÐÔ£¬ÓëÆÕͨϸ¾úÐÔ·ÎÑ×ÀàËÆ£¬³£¼û3ÖÖÀàÐÍ£¬¼´·ÎÑ×ÐÍ16Àý£¨29ª±6%£©¡¢Ö§Æø¹Ü·ÎÑ×ÐÍ27Àý£¨50ª±0%£©¡¢Ñ×ÐÔ½á½ÚÐÍ4Àý£¨7ª±4%£©¡£

¡¡¡¡2ª±5  ÖÎÁƺÍÔ¤ºó  ÒÑ·¢ÉúÁ˷β¿Õæ¾ú¸ÐȾµÄ²¡Àý£¬È«²¿½ÓÊÜ¿¹Õæ¾úÖÎÁÆ£¬51ÀýÓ÷ú¿µßòÖÎÁÆ£¬3ÀýÓÃÒÁÇú¿µßòÖÎÁÆ¡£54Àý·Î²¿Õæ¾ú¸ÐȾ»¼ÕßȬÓú»òºÃת49Àý£¨90ª±7%£©£¬Îޱ仯2Àý£¨3ª±7%£©£¬¶ñ»¯ËÀÍö3Àý£¨5ª±6%£©¡£

¡¡¡¡3  ÌÖÂÛ

¡¡¡¡ÔºÄڷβ¿Õæ¾ú¸ÐȾ¿É·¢ÉúÔÚ¶àÖÖºôÎüϵͳ¼²²¡µÄ»ù´¡ÉÏ£¬ÆäÖÐÒÔCOPD£¨Õ¼51ª±8%£©×îΪ¶à¼û£¬·ÎÑ×¼°Ïø´­Ò²Õ¼ÖØҪλÖ㬷ֱðÕ¼22ª±2%ºÍ11ª±1%¡£ÔÚ¸ÐȾµÄÒ×»¼ÒòËØÖг£¼ûµÄÊdz¤ÆÚÓ¦ÓùãÆ׿¹ÉúËØ£¬µÍµ°°×Ѫ֢£¬³¤ÆÚÓ¦ÓÃÌÇƤÖʼ¤ËØ£¬ºÏ²¢ÌÇÄò²¡Ò²ÊÇÒ»¸öÖØÒªµÄÒ×»¼ÒòËØ¡£ºôÎüÄڿƲ¡·¿»¼Õ߶àΪÀÏÄêÈË£¬ÕâЩ»¼ÕßÄêÁä´ó£¬¶àÓз´¸´·Î²¿¸ÐȾ£¬ºôÎüµÀ·ÀÓùÆÁÕÏÊÜË𣬺ôÎü¹¦Äܲ»È«£¬ÃâÒß¹¦ÄܵÍÏ£¬¾úȺʧµ÷£¬ÁíÒ»·½Ãæ¿ÉÄÜ´æÔÚÌÇÄò²¡¡¢¸ÎÉö¹¦Äܲ»È«¡¢µÍµ°°×Ѫ֢µÈ¶àÖÖÎÊÌ⣬ͬʱÔÚÖÎÁƹý³ÌÖпÉÄÜ´æÔÚ³¤ÆÚÓ¦ÓùãÆ׿¹ÉúËØ¡¢ÌÇƤÖʼ¤ËØ£¬ÒÔ¼°»úеͨÆøµÈÒòËØ£¬±¾×é×ÊÁÏÖкϲ¢2ÖÖ»ò2ÖÖÒÔÉÏ¿ÉÄÜÒ×»¼ÒòËصĻ¼Õß¾ÍÓÐ46Àý£¬Õ¼85ª±2%¡£Óɴ˿ɼû£¬ºôÎüÄڿƲ¡·¿»¼ÕßÌرðÊÇÓÐÑÏÖØ»ù´¡¼²²¡£¬Í¬Ê±´æÔÚ¶àÖÖÒ×»¼ÒòËصĻ¼Õß¼«Ò×·¢ÉúÔºÄڷβ¿Õæ¾ú¸ÐȾ¡£

¡¡¡¡±¾Ñо¿·¢ÏÖ£¬ÅàÑø³öµÄÕæ¾úÖнÍĸ¾úÊô×î¶à£¬ÆäÖа×É«ÄîÖé¾úÕ¼61ª±1%£¬¹â»¬¼ÙË¿½Íĸ¾úÕ¼13%£¬ÆäËû½Íĸ¾úÕ¼20ª±4%£¬ÁíÍ⻹·¢ÏÖÇú¾ú3Àý¡£Óë¹úÄÚÍâ´ó¶àÊý±¨µÀÏàËÆ¡£·Î²¿Õæ¾ú¸ÐȾÔÚÁÙ´²±íÏÖÒÔ¼°Ðز¿XÏß±íÏÖÉÏÎÞÌØÒìÐÔ£¬²¢ÇÒÒò¶àÊǼ̷¢¸ÐȾ£¬³£Óë·Î²¿Ô­·¢²¡ºÜÄÑÍêÈ«Çø·Ö£¬ÔçÆÚÕï¶Ï±È½ÏÀ§ÄÑ¡£µ«ÔÚÔ­·¢²¡µÄÕïÁƹý³ÌÖУ¬³öÏÖºôÎüϵͳ֢״¡¢ÌåÕ÷£»
·¢ÈÈ¡¢°×ϸ°ûÔö¼Ó£»
Ó°ÏñѧÌáʾÓÐеIJ»ÄܽâÊ͵ķβ¿½þÈóÓ°£»
Ó¦Óÿ¹ÉúËØÖÎÁƹý³ÌÖУ¬²¡Çé¶ñ»¯£¬ÓÃÒ»°ãϸ¾ú¸ÐȾ²»ÄܽâÊ͵IJ¡ÀýÓ¦¿¼ÂǷβ¿Õæ¾ú¸ÐȾµÄ¿ÉÄÜ£¬ºÏ¸ñµÄ̵Һ»òÖ§Æø¹Ü·ÎÅݹàÏ´Òº¾­Ö±½Ó¾µ¼ì·¢ÏÖ¾úË¿£¬Õæ¾úÅàÑø2´ÎÑôÐԵĻù´¡ÉϽáºÏÁÙ´²¿É×ö³öÔºÄڷβ¿Õæ¾ú¸ÐȾµÄÕï¶Ï¡£
ÔÚÖÎÁÆ·½Ã棬ĿǰÕë¶ÔÕæ¾ú¸ÐȾÖÎÁÆ¿ÉÑ¡ÔñµÄÒ©Îï²»¶à£¬Ö÷ÒªÓÐÈýßòÀ࣬È磺·ú¿µßò¡¢ÒÁÇú¿µßò¡¢·üÁ¢¿µßò£»
¶àÏ©À࣬È磺Á½ÐÔùËØB¡¢5-·úÄòà×ऺÍÖÆù¾úËصȡ£¹úÍâ×ÊÁÏÈÏΪ¶ÔÓÚÑÏÖصÄÕæ¾ú¸ÐȾ²¡ÀýÌرðÊÇÈ«ÉíÕæ¾ú¸ÐȾÕßÓ¦Ê×Ñ¡Á½ÐÔùËØBÖÎÁÆ£¬µ«Æ䶾¸±×÷Óýϴ󡣱¾×é×ÊÁÏÖзβ¿Õæ¾ú¸ÐȾµÄÖ÷Òª²¡Ô­¾úÊǽÍĸ¾úÊô£¬¶ÔÓÚ51Àý»¼ÕßÎÒÃÇÑ¡ÔñÁËͬÑù¶Ô½Íĸ¾úÓнϸߵĿ¹¾ú»îÐÔ£¬µ«Ïà¶Ô¶¾ÐԵͣ¬°ëË¥ÆÚ³¤¡¢¿Ú·þÉúÎïÀûÓöȸߣ¬ÔÚ×éÖ¯ÌåÄÚ·Ö²¼¹ã·ºµÄ·ú¿µßòÖÎÁÆ£¬È¬Óú»òºÃת47Àý£¬ÓÐЧÂÊΪ92ª±2%¡£3ÀýÇúù¾ú¸ÐȾ»¼ÕßÓÃÒÁÇú¿µßòÖÎÁÆ£¬ÓÐЧÂÊ66ª±7%¡£ÎÒÃÇÔÚ¿¹Õæ¾úÖÎÁÆͬʱÒà»ý¼«µÄ¿ØÖÆÔ­·¢²¡£¬ºÏÀíÑ¡ÔñʹÓÿ¹ÉúËØ£¬ÑϸñÕÆÎÕÌÇƤÖʼ¤ËصÄÓÃÒ©Ö¸Õ÷£¬±ÜÃⳤÆÚ´ó¼ÁÁ¿Ê¹Ó㬾ÀÕýµÍµ°°×Ѫ֢£¬Ìá¸ß»úÌåÃâÒß¹¦Äܺͻý¼«¿ØÖÆѪÌǵÈ×ÛºÏÖÎÁÆ£¬ÓÐЧµØÌá¸ßÁ˷β¿Õæ¾ú¸ÐȾµÄÖÎÓúÂÊ¡£Òò´Ë£¬ÔÚÔºÄڷβ¿Õæ¾ú¸ÐȾµÄÖÎÁÆÖУ¬¼°Ê±Ó¦ÓøßЧµÄ¿¹Õæ¾úÒ©Í⣬»ý¼«¿ØÖÆÔ­·¢²¡ºÍÒ×»¼ÒòËصÄ×ÛºÏÖÎÁƶÔÓÚÌá¸ßÕæ¾ú¸ÐȾµÄÖÎÓúÂÊͬÑù¼«ÎªÖØÒªµÄ£¬Ó¦ÒýÆð¹ã´óÁÙ´²¹¤×÷Õߵĸ߶ÈÖØÊÓ¡£

¡¡¡¡¡¾²Î¿¼ÎÄÏס¿

¡¡¡¡1 ǮС˳£¬ÖìÔªç壬ÐíÎıø£¬µÈ.127Àý·Î²¿Õæ¾ú¸ÐȾµÄÁÙ´²·ÖÎö.Öлª½áºËºÍºôÎüÔÓÖ¾£¬2000£¬23£¨7£©£º417-419.

¡¡¡¡2 ÖлªÄÚ¿ÆÔÓÖ¾±à¼­Î¯Ô±»á.ÇÖÏ®ÐԷβ¿Õæ¾ú¸ÐȾµÄÕï¶Ï±ê×¼ÓëÖÎÁÆÔ­Ôò£¨²Ý°¸£©.ÖлªÄÚ¿ÆÔÓÖ¾£¬2006£¬45£¨8£©£º697-700.

¡¡¡¡3 Àî´ÓÈÙ£¬ÅíÉÙ»ª£¬À£¬µÈ.ÉÕæ¾úÒ½Ôº¸ÐȾµÄÁÙ´²µ÷²éÓëÄÍÒ©ÏÖ×´Ñо¿.ÖлªÒ½Ôº¸ÐȾѧÔÓÖ¾£¬2002£¬12£¨7£©£º485-487.

¡¡¡¡4 Jarvis WR.Epidemiology of nosocomial infections£¬with emphasis on sepsis.CID£¬1995£¬20(6):1526-1530.

¡¡¡¡5 Kauffman CA. When to suspect fungal infection as the cause of nonresolving pneunmonia.J Respir Dis£¬1999£¬20:283-293.

ÍƼö·ÃÎÊ:ÄÚ¿Æ ±ÏÒµÂÛÎÄ Ò½Ñ§

°æȨÉùÃ÷£º

1¡¢±¾ÍøÕ¾·¢²¼µÄ×÷ÎÄ¡¶ÄÚ¿Æҽѧ±ÏÒµÂÛÎÄ¡·Îª°®×÷ÎÄÍø×¢²áÍøÓÑÔ­´´»òÕûÀí£¬°æȨ¹éÔ­×÷ÕßËùÓУ¬×ªÔØÇë×¢Ã÷³ö´¦£¡

2¡¢±¾ÍøÕ¾×÷ÎÄ/ÎÄÕ¡¶ÄÚ¿Æҽѧ±ÏÒµÂÛÎÄ¡·½ö´ú±í×÷Õß±¾È˵Ĺ۵㣬Óë±¾ÍøÕ¾Á¢³¡Î޹أ¬×÷ÕßÎÄÔð×Ô¸º¡£

3¡¢±¾ÍøÕ¾Ò»Ö±ÎÞ˽Ϊȫ¹úÖÐСѧÉúÌṩ´óÁ¿ÓÅÐã×÷ÎÄ·¶ÎÄ£¬Ãâ·Ñ°ïͬѧÃÇÉóºË×÷ÎÄ£¬ÆÀ¸Ä×÷ÎÄ¡£¶ÔÓÚ²»µ±×ªÔØ»òÒýÓñ¾ÍøÄÚÈݶøÒýÆðµÄÃñÊ·×Õù¡¢ÐÐÕþ´¦Àí»òÆäËûËðʧ£¬±¾Íø²»³Ðµ£ÔðÈΡ£

ÈÈÃÅרÌâ